Behavioral, Neurochemical and Neuroendocrine Effects of Abnormal Savda Munziq in the Chronic Stress Mice
Figure 2
Behavioral effect of ASMq in the passive avoidance task. ASMq or vehicle was orally administered once a day for 14 days (2.53, 5.06, and 10.12 g/kg/day). The last treatment with ASMq or vehicle was administered 120 min before an acquisition trial. Twenty four hours after the acquisition trial, a 5 min retention trial was carried out. Data are expressed as means ± SEM (n = 10/group). # compared with the vehicle-treated group (Gr. I). ** compared with the vehicle-treated model group (Gr. II).
